Results 121 to 130 of about 1,597 (169)

No Evidence that <i>CD33</i> rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group. [PDF]

Dis Markers, 2022
Castaño-Bonilla T, Barragán E, Sargas C, Sanz A, Algarra L, Herrera-Puente P, García-Boyero R, Barrios M, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Serrano-López J, Martínez-López J, Martínez-López J, Sayas-Lloris MJ, Olave MT, Riaza-Grau R, Castillo TB, Larrayoz MJ, Amigo R, Jiménez-Velasco A, Sánchez J, Ayala R, Blas C, Lainez D, Serrano-López J, Sanz MA, Alonso-Domínguez JM, Montesinos P.   +29 more
europepmc   +1 more source

Influence of expanded graphene on physical and chemical properties, and <i>in vitro</i> toxicity of glass ionomer cements for luting. [PDF]

Biomater Investig Dent
Martins SP, Geraldino Monteiro CM, da Silva RR, Pintor AVB, Magno MB, Visconti MA, Villela Romanos MT, de Menezes LR, Maia LC, Pithon MM.   +9 more
europepmc   +1 more source

Improving sepsis care with Artificial Intelligence. What would Illich say? [PDF]

Crit Care Sci
Komorowski M, Rincon T, Lopez MDPA, Deliberato RO, Celi LA.   +4 more
europepmc   +1 more source

Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study. [PDF]

Cancers (Basel)
Solana-Altabella A, Navarro-Vicente I, Rodríguez-Arbolí E, Noriega V, Serrano J, Bernal T, Carrasco-Baraja V, Garcia-Boyero R, Olivier Cornacchia C, Algarra L, López-Briz E, Mena-Durán A, Solano-Tovar J, Botella-Prieto C, Sánchez-Sánchez S, Bergua-Burgues JM, Lloret-Madrid P, Rodenas-Rovira M, Boluda B, Cano-Ferri I, Acuña-Cruz E, Rodríguez-Veiga R, Torres-Miñana L, Centelles-Oria M, Poveda-Andrés JL, Martínez-Cuadrón D, Montesinos P.   +26 more
europepmc   +1 more source

Los mecanismos alternativos a la Jurisdicción para la resolución de conflictos en la empresa familiar argentina

Programa de Doctorado en Derecho por la Universidad Carlos III de MadridPresidente: Juan Carlos Veiga.- Secretario: Bernardo Pedro Carlino.- Vocal: Marta García ...
Farall, María Elvira
core  

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy. [PDF]

Nature
Ng KW, Boumelha J, Enfield KSS, Almagro J, Cha H, Pich O, Karasaki T, Moore DA, Salgado R, Sivakumar M, Young G, Molina-Arcas M, de Carné Trécesson S, Anastasiou P, Fendler A, Au L, Shepherd STC, Martínez-Ruiz C, Puttick C, Black JRM, Watkins TBK, Kim H, Shim S, Faulkner N, Attig J, Veeriah S, Magno N, Ward S, Frankell AM, Al Bakir M, Lim EL, Hill MS, Wilson GA, Cook DE, Birkbak NJ, Behrens A, Yousaf N, Popat S, Hackshaw A, TRACERx Consortium, CAPTURE Consortium, Hiley CT, Litchfield K, McGranahan N, Jamal-Hanjani M, Larkin J, Lee SH, Turajlic S, Swanton C, Downward J, Kassiotis G.   +50 more
europepmc   +1 more source

A Switchable Deep Eutectic System Based on Diarylethene. [PDF]

ACS Omega
Cruz H, Jordão N, Santiago S, Mena S, Santos AFM, Viciosa MT, Zalewska K, Branco LC, Hernando J, Guirado G.   +9 more
europepmc   +1 more source

Pneumococci remain the main cause of complicated pediatric pneumonia in the post-pandemic era despite extensive pneumococcal vaccine use. [PDF]

Pneumonia (Nathan)
Gomes-Silva J, Pinho MD, Friães A, Ramirez M, Melo-Cristino J, Silva-Costa C, Portuguese Group for the Study of Streptococcal Infections, Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society.   +7 more
europepmc   +1 more source

Cost-effectiveness of procalcitonin-guided antibiotic duration for hospitalized patients with sepsis. [PDF]

Crit Care
Stevenson M, Forsyth JE, Hossain A, Lall R, Dark P, ADAPT-Sepsis collaborators.   +5 more
europepmc   +1 more source